OCGN
Ocugen Inc
1.00$
+2.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.6% | -19.8% | -21.7% | +52.8% | +33.1% | -21.8% | -16.9% | +7.5% | -23.1% | +28.5% | +118.3% | |
| – | -24.0% | -30.2% | -37.9% | +118.5% | +51.7% | -28.7% | -25.2% | +14.5% | -35.3% | +58.4% | +176.8% | |
| – | -26.2% | -33.2% | -40.5% | +146.5% | +51.2% | -35.4% | -28.5% | +20.6% | -43.0% | +71.5% | +214.1% | |
| – | -26.2% | -33.2% | -40.5% | +146.5% | +51.2% | -35.4% | -28.5% | +20.6% | -43.0% | +71.5% | +214.1% | |
| – | +47.2% | -10.2% | +9.7% | -9.8% | +147.9% | -8.1% | +4.1% | +7.0% | +4.4% | -9.5% | +175.5% | |
| – | +53.5% | -6.1% | +12.0% | -12.3% | +37.0% | -21.8% | +6.5% | +13.2% | +13.2% | -10.1% | +542.7% | |
| – | -68.4% | +228.4% | -6.3% | +1.5% | +2.9% | -60.1% | +15.9% | +0.2% | +146.5% | +177.8% | +1,321.3% | |
| – | +8.6% | -45.4% | +95.9% | -55.9% | +184.0% | -24.0% | +31.4% | +8.0% | +35.6% | -47.7% | +58.6% | |
| – | +87.3% | -45.3% | +1.2% | +1.2% | +1,640.6% | +1.2% | +1.3% | +1.3% | -3.0% | -12.2% | -92.9% | |
| – | -30.5% | -25.4% | -44.1% | +140.0% | -27.1% | -46.3% | -80.8% | +15.8% | -444.4% | – | -385.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.3% | +0.0% | +8.1% | +4.6% | +0.4% | +0.0% | +4.1% | +2.7% | +2.6% | +5.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.